Paul Wagner | CEO |
Dan Birch | CMO |
Tony Riley | CFO |
Mohit Bansal | Citigroup |
Kumar Raja | Brookline Capital Markets |
Michael Higgins | Ladenburg Thalmann |
Kalpit Patel | B. Riley |
Welcome to Forte Biosciences First Quarter 2021 Conference Call. My name is David and I will be the operator for this call.
On the call are Paul Wagner, Chairman and Chief Executive Officer of Forte Biosciences; Dan Birch, Forte's Chief Medical Officer, and Tony Riley, Forte's Chief Financial Officer.
Before I turn the call over to Paul and Tony to discuss the business and financial highlights of the first quarter, I'd like to make a comment regarding forward looking statements. Many of the statements made during the call today are forward-looking statements, including statements with respect to the company's cash position, the potential development timeline of the company's product candidate.